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Objectives* (describe the learning outcomes) 
A special technique to make a better result in natural shape of chin and reduce the 
opportunity of granuloma recurrence caused by silicone injection 
 
Introduction 
Silicone liquid injection have been used for cosmetic for more than 40 years. Many 
complications have been reported such as granulomatous, inflammatory responses, 
migration, and discoloration of the tissue. In 1992, the FDA has banned silicone 
liquid  injection for cosmetic uses. However, silicone injection is still being practiced illegally. 
Liquid silicone injected to chin cause granuloma, inflammation, and a witch looked like face.   
 
Materials / method 
Many methods has been used to remove the granuloma but excision were the best among  
all. We used knife to do the excision, only to the granuloma without damaging the skin.The 
Incision from under the skin in submental area and then we cut the excess skin for make 
better shape of chin. Using a knife to remove silicone granuloma is better that curretation, 
and for the inflammation we use corticosteroid injection. 
 
Results 
Combination  knife with special technique and corticosteroid injection can make a better 
result in natural shape of chin and reduce the opportunity of silicone granuloma recurrence. 
 
Conclusion 
Granuloma on the chin can be removed by excision with special technique which result in 






Injectable-grade silicone for medical use has been manufactured widely since the element has 
been known for its stable and inert characteristics [3, 4]. It includes the use of silicone oil, which has 
been utilized in the treatment of complicated retinal detachment and heavy silicone oil tamponade. The 
treatment seems to offer promising results, particularly on improving visual acuity as well as great 
results on some anatomical parameters; however, there are some concerns as it may cause several 
complications such as cataract, increased ocular pressure, heavy silicone oil emulsification, and mild 
inflammatory reaction [5, 6, 7]. 
Injectable-grade silicone has also been widely used in the form of silicone oil injection. Some 
studies have suggested that it may have an essential role in reducing the risk of developing diabetic foot 
ulcer due to its pressure-reducing properties; therefore, it can maintain plantar tissue thickness and 
alleviate symptoms of diabetic foot ulcer, which may be associated with foot biomechanics [8, 9]. 
Although it brings advantages, silicone injection may still develop some complications, either 
local or systemic complications. Local complications may include formation of palpable nodule 
surrounding injection site, arthralgia, fatigue, electrical neuropathy, and electrical sensation [10], while 
systemic complications may also occur in the form of lymphadenopathy, renal disease, and hepatic 
disease. It indicates that the injected silicone can migrate from injection site to other organs causing 
local and systemic complications. An animal experimental study in mouse model may explain the 
pathogenesis of such complications. The study has demonstrated that macrophage of skin tissue may 
engulf the injected silicone and the silicone may be distributed through lymphatic circulation, 
ultimately causing accumulation in lymph nodes, adrenal glands, and the kidney, liver, and spleen as 
well as granuloma formation in the skin [11]. Complications due to silicone injection, particularly the 
granuloma formation may be dose-dependent. A study by Harlim has demonstrated that granuloma 
formation could be developed when there is a large amount of silicone exposure as the study only found 
a low level of silicone without any granuloma formation in the normal skin (Figure 1) [2]. 
 Cultural changes have been encouraging people to pursue their passion on beauty and youth; 
therefore, cosmeticology has been rapidly growing. With technological advances, more mixed drug 
ingredients have been added to cosmetic products in order to beautify their customers. Thus, it may 
indirectly increase the use of topical cosmetics that usually contain silicone; therefore, it will lead to 
increase silicone uptake to the skin. It has raised a concern that the prolonged and continuous use of 




Figure 1. The level of silicon (Si) in normal subjects who had never received silicone injection (never 




Granuloma is a form of localized nodular inflammation, which is found in tissues [7]. On 
examination, there is a tumor-like mass or node of granulation tissue with active fibroblast growth and 
capillaries that contain epithelial-like macrophages surrounded by mononuclear cells, lymphocytes, 
and sometime multinucleated Datia cells present at the central core of granuloma [16]. 
On clinical point of view, silicone granuloma is characterized by the presence of complications 
of silicone. There are usually granuloma nodes, migrating silicone, wider nose, and signs of 
inflammation such as redness and swelling depending on the stage. 
 
Management  
The management of silicone-induced granuloma is often difficult due to migrating silicone and 
some of the silicone penetrating into the skin reaching the epidermis. In general, the management of 
granuloma can be categorized into two, i.e., surgical and pharmacological treatments. The management 
of nasal silicone granuloma is adjusted for the occurring complications. We must remove granuloma, 
which is under the skin; afterward, we perform excision of the excessive skin or implant insertion, 
creating a firmer and cosmetically more attractive skin. Remaining fibrosis or granuloma can be treated 
using steroid injection, and laser therapy is performed for redness. 
 
Recommendation for surgical care  
Granuloma formation occurs due to the presence of foreign body. Skin granuloma will cause a 




The preoperative preparation is similar to all kinds of skin surgery. A consultation prior to 
surgical procedure is necessary so that the doctor can perform both physical and psychological 
evaluation for the candidate. The patient should be informed about surgical procedure and the result 
may not be perfect as clean silicone injection can never be performed and there is a possibility of 
swelling. Patients with extreme high expectation will file their complaints in the future. 
During the consultation, we must find out about coagulation disorder, either primary or 
secondary, either due to medication of pharmacological treatment or supplementation. The patients are 
advised to avoid food or medication that may prolong the bleeding time within 1 or 2 weeks prior to the 
procedure such as anticoagulants, aspirin, ginseng, garlic, cod liver oil, anticholesterol agent, vitamin 
E, warfarin, and Ginkgo biloba. 
Curettage procedure of nasal silicone granuloma is similar to skin graft procedure, in which the 
covering skin must be viable. On curettage, the skin will be thinner, and it can be necrotic if there is 
poor vascularization. Other issues that should come into our consideration are alcohol intake, smoking 
habit, metabolic disorder, and poor nutrition. Blood pressure and diabetes mellitus must be well-
controlled [17, 18, 19]. 
 
Informed consent  
 When a skin surgeon decides to perform a surgical procedure, both doctor and patient must 
consequently understand the impact, risk, and advantages of the procedure. First, the doctor needs to 
explain the diagnosis and the procedure that will be performed. Treatment of nasal silicone injection is 
a combination of medical therapy and cosmetic procedure because when it is left untreated, there will 
be changes such as migration, granuloma, and continuous inflammation. The risks and the advantages 
of the procedure should be emphasized. Moreover, the procedure during the surgery and the expected 
result after surgery need to be explained. Possible risks that may develop such as infection and its 
prevention including the use of antibiotics must also be explained. Patients must know other probable 
risks such as bleeding, crooked nose, wound scar that probably occurs, asymmetrical nostrils, an 
implant impression on the skin, granuloma or fibrosis that cannot be cleaned up, persistent redness of 
skin color, and other modalities of treatment that need to be carried out after the surgical procedure. It 
should also be explained that the results probably may be imperfect, particularly for patients with 
unrealistic wish. Results of discussion and patient’s consent are written on an informed consent form, 
which is subsequently signed by the doctor and patient. 
 
Technique and procedure   
Every granuloma in the skin that causes cosmetic problem must be removed. Granuloma at 
inflammatory phase must also be removed to prevent the extension of inflammation. Local or general 
anesthesia could be used for procedures of skin excision, granuloma curettage. Instruments that must 




The management of silicone-induced granuloma depends on the affected area; however, 
basically a doctor will first make a design planning. Next, the doctor will perform procedures according 
to the design or images and following the plan that has been discussed with the patient. 
Depending on the occurring complication, we evaluate whether we need to remove the 






First, We have to make the boundary of granuloma and make the design of excision  area just   









You have to cut the granuloma with knife jut under the skin, you have carefully this time because the 









After take out the granuloma by knife, and curettage on  the lateral part , we can stitching it 
 
 
Postoperative Management  
1. Use nasal splint or gauze for a week to prevent splint displacement. 
2. Prescribing antibiotics for 5–7 days. 
3. Prescribing analgetics every 4–6 hours as necessary. 
4. Prescribing anti-inflammatory drugs for 5–7 days. 
5. Normal saline solution for the chin to overcome postsurgical nasal congestion. 
6. To reduce swelling, apply cold compress to periorbital within the first 48 hours. 
7. When sleeping, the patient should keep the head elevated approximately 45°. 
8. If there is a seroma, we can remove it by suctioning using syringe during the follow-up visit. 
9. Avoid any trauma for 2 weeks. 
10. Remove the stitches on day 10–14. 
11. Have a normal diet, but avoid foods that cause excess lip movement such as apples and corn on 
the cob for 2 weeks after surgery. 
 
 
Adjunctive Therapy to Overcome Other Complications 
The principle of therapy in managing patients with granuloma due to silicone injection is 
preventing the development of inflammation as it will cause extention of damage. 
Evacuation of silicone-induced granuloma should be performed since the liquid silicone in the 
tissue is persistent and will continuously induce immune response. Although the granuloma has been 
excised, the remaining silicone, which has migrated to all direction and has been absorbed in the skin, 
cannot be removed, and therefore, it may cause recurrent granuloma. The remaining inflammation, 
both granuloma and fibrosis, requires further treatment. 
For granuloma or fibrosis that cannot be removed by surgical procedure, other modalities are 
required to treat the remaining fibrosis and inflammation that can still be seen on the skin, i.e., skin 
redness and telangiectasia. 
 
Fibrosis and remaining granuloma  
Some case reports suggest that to treat silicone-induced granuloma, intralesion injection can 
be used as well as topical treatment of pimecrolimus, which is applied two times daily for 3 months. 
Topical imiquimod can be used for 8 weeks as well as minoxillin, allopurinol, and oral prednisone at 
the dose of 30 mg/day [22, 23]. Results of those treatment have not been satisfying although intralesion 
injection of triamsinolone is more significant for treating the occurring inflammation [24]. 
Granuloma and remaining fibrosis may also be treated with subdermal injection of 
triamcinolone acetonide at a dose of 10 mg/ml or a combination of triamcinolone acetonide and 5-
fluorouracil. Steroid injection can be performed at the earliest within 2 weeks after wound closure. 
The injection is performed once or twice weekly as many as five to seven times. The dose 
depends on the amount of remaining granuloma and fibrosis, and usually it is at dose of 0.2–0.4 cc per 
injection. 
Etanercept, which works on TNF-α receptor and Fc-IgG1 binding, has been reported providing 
good result for silicone granuloma [25, 26, 27]. The administration of this drug at the dose of 50 mg 
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